Available EU DMF/CEP
EU DMF
CEP
API Status
Commercial
Pipeline
Therapeutic Category
Alimentary tract & metabolism
Anti-infectives for systemic use
Antipyretic, analgesic and anti-inflammatory
Antineoplastic & immunomodulating agents
Blood & blood forming organs
Cardiovascular system
Genito-urinary system & sex hormones
Injectable forms
Musculo-skeletal system
Nervous system
Opthalmological preparations
Respiratory system
Available US DMF
US DMF
Available Japanese/Chinese DMF
Japanese DMF
Chinese DMF
Korean DMF

Pentoxifylline

CAS No.

1677687

Innovator/marketer

N/A

Polymorphic form

Form I

Therapeutic Area

Cardiovascular system

Status

Commercial

EU DMF readiness

US DMF readiness

020976

CEP

Other documentation

Chinese DMF - under registration

Available also in injectable form

Drug description:

Pentoxifylline is a xanthine derivative belongs to vasodilator agent. It is indicated for the treatment of peripheral vascular disease, including intermittent claudication on the basis of chronic occlusive arterial disease of the limbs and for the treatment of acute arterial circulatory disorders of the eye.
It is formulated as extended release tablets for oral route of administration and as solution for injection infusion for intravenous route of administration.

Mechanism of action:

Pentoxifylline inhibits phosphodiesterase, resulting in increased levels of cyclic adenosine monophosphate (cAMP) in erythrocytes, endothelium, and the surrounding tissues. This leads to vasodilation, improves erythrocyte flexibility, and enhances blood flow. In addition, the increased level of cAMP in platelets inhibits platelet aggregation, which may contribute to a reduction in blood viscosity.

DISCLAIMER
Products protected by valid patents are not offered for commercial sale in countries where the sale of such products constitutes patent infringement but are offered solely for uses reasonably related to the development and submission of information under a law regulating the manufacture, use or sale of drugs. It is within the buyer’s responsibility and liability to check the patent situation of the product in the imported market(s).

OK